WallStreetZenWallStreetZen

NASDAQ: STOK
Stoke Therapeutics Inc Stock Ownership - Who owns Stoke Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Stoke Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Barry TichoMed2026-09-011,600$31.06
$49.69kSell
Barry TichoMed2026-09-013,945$30.51
$120.37kSell
Jonathan AllanCLO;Sec2026-08-18145$32.47
$4.71kSell
Barry TichoMed2026-08-18242$32.47
$7.86kSell
Barry TichoMed2026-08-184,525$32.01
$144.83kSell
Edward M. Md KayeDirector2026-08-1811,930$32.01
$381.84kSell
Jonathan AllanCLO;Sec2026-08-182,716$32.01
$86.93kSell
Edward M. Md KayeDirector2026-08-18637$32.47
$20.68kSell
Barry TichoMed2026-08-035,907$28.95
$171.01kSell
Barry TichoMed2026-08-031,269$29.45
$37.38kSell

1 of 9

STOK insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when STOK insiders and whales buy or sell their stock.

STOK Shareholders

What type of owners hold Stoke Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Seth Loring Harrison52.61%33,948,426$982.13MInsider
Apple Tree Partners IV LP26.60%17,161,713$496.49MInsider
Trust Skorpios6.05%3,906,181$113.01MInsider
Rtw Investments LP5.49%3,544,248$102.54MInsider
Redmile Group LLC1.04%671,808$19.44MInsider
Adrian R. Krainer0.44%283,302$8.20MInsider
Edward M. Md Kaye0.19%124,557$3.60MInsider
Arthur Tzianabos0.05%31,339$906.64kInsider
Arthur A. Levin0.03%22,216$642.71kInsider
Gene Liau0.03%21,351$617.68kInsider

1 of 3

STOK vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
STOK0.12%92.67%Net SellingNet Selling
XNCR0.11%42.93%Net Selling
MRVI0.05%60.30%Net SellingNet Selling
SEPN0.10%58.91%Net SellingNet Selling
VIR0.09%30.90%Net Selling
View Top Biotech Stocks

Stoke Therapeutics Stock Ownership FAQ

Who owns Stoke Therapeutics?

Stoke Therapeutics (NASDAQ: STOK) is owned by 0.12% institutional shareholders, 92.67% Stoke Therapeutics insiders, and 7.21% retail investors. Seth Loring Harrison is the largest individual Stoke Therapeutics shareholder, owning 33.95M shares representing 52.61% of the company. Seth Loring Harrison's Stoke Therapeutics shares are currently valued at $965.15M.

If you're new to stock investing, here's how to buy Stoke Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.